Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 416

1.

Validation in China of a non-invasive salivary pepsin biomarker containing two unique human pepsin monoclonal antibodies to diagnose gastroesophageal reflux disease.

Wang YF, Yang CQ, Chen YX, Cao AP, Yu XF, Yu Y, Zhang ZY, Shen XZ, Liu F, Zhong L, Wang YX, Liu ZJ, Shi YH, Zhong J, Li JN, Lan Y, Lenham RK, Woodcock AD, Dettmar PW, Fang JY.

J Dig Dis. 2019 Jun;20(6):278-287. doi: 10.1111/1751-2980.12783.

2.

Letter: studies of salivary pepsin in patients with gastro-oesophageal reflux disease.

Dettmar PW, Woodcock AD, Wilcox MD, Chater PI, Pearson JP.

Aliment Pharmacol Ther. 2019 May;49(9):1248-1249. doi: 10.1111/apt.15213. No abstract available.

3.

Our patients and our planet-holistic considerations for inhaler choice.

Wilkinson A, Hillman T, Hopkinson NS, Janson C, Smith J, Woodcock AA.

Lancet Respir Med. 2019 Mar;7(3):e11. doi: 10.1016/S2213-2600(19)30035-9. No abstract available.

4.

Benefit and safety of fluticasone furoate/vilanterol in the Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) according to baseline patient characteristics and treatment subgroups.

Bakerly ND, Woodcock A, Collier S, Leather DA, New JP, Crawford J, Harvey C, Vestbo J, Boucot I.

Respir Med. 2019 Feb;147:58-65. doi: 10.1016/j.rmed.2018.12.016. Epub 2019 Jan 10.

5.

Patient-reported outcomes with initiation of fluticasone furoate/vilanterol versus continuing usual care in the Asthma Salford Lung Study.

Svedsater H, Jones R, Bosanquet N, Jacques L, Lay-Flurrie J, Leather DA, Vestbo J, Collier S, Woodcock A.

Respir Med. 2018 Aug;141:198-206. doi: 10.1016/j.rmed.2018.06.003. Epub 2018 Jun 6.

6.

Marijuana use among adolescent multiple tobacco product users and unique risks of dual tobacco and marijuana use.

Pulvers K, Ridenour C, Woodcock A, Savin MJ, Holguin G, Hamill S, Romero DR.

Drug Alcohol Depend. 2018 Aug 1;189:80-89. doi: 10.1016/j.drugalcdep.2018.04.031. Epub 2018 May 31.

7.

Effectiveness versus efficacy trials in COPD: how study design influences outcomes and applicability.

Woodcock A, Boucot I, Leather DA, Crawford J, Collier S, Bakerly ND, Hilton E, Vestbo J.

Eur Respir J. 2018 Feb 21;51(2). pii: 1701531. doi: 10.1183/13993003.01531-2017. Print 2018 Feb.

8.

A randomised pragmatic trial of corticosteroid optimization in severe asthma using a composite biomarker algorithm to adjust corticosteroid dose versus standard care: study protocol for a randomised trial.

Hanratty CE, Matthews JG, Arron JR, Choy DF, Pavord ID, Bradding P, Brightling CE, Chaudhuri R, Cowan DC, Djukanovic R, Gallagher N, Fowler SJ, Hardman TC, Harrison T, Holweg CT, Howarth PH, Lordan J, Mansur AH, Menzies-Gow A, Mosesova S, Niven RM, Robinson DS, Shaw DE, Walker S, Woodcock A, Heaney LG; RASP-UK (Refractory Asthma Stratification Programme) Consortium.

Trials. 2018 Jan 4;19(1):5. doi: 10.1186/s13063-017-2384-7.

9.

Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial.

Woodcock A, Vestbo J, Bakerly ND, New J, Gibson JM, McCorkindale S, Jones R, Collier S, Lay-Flurrie J, Frith L, Jacques L, Fletcher JL, Harvey C, Svedsater H, Leather D; Salford Lung Study Investigators.

Lancet. 2017 Nov 18;390(10109):2247-2255. doi: 10.1016/S0140-6736(17)32397-8. Epub 2017 Sep 10. Erratum in: Lancet. 2017 Nov 18;390(10109):e40. Lancet. 2018 Feb 3;391(10119):430.

PMID:
28903864
10.

Clinical trial research in focus: time to reflect on the design of exacerbation trials in COPD.

Vestbo J, Woodcock A.

Lancet Respir Med. 2017 Jun;5(6):466-468. doi: 10.1016/S2213-2600(17)30177-7. Epub 2017 May 26. Review. No abstract available.

PMID:
28664846
11.

Commentary: View from the frontline of pragmatic trials.

Woodcock A.

BMJ. 2017 Jun 14;357:j2837. doi: 10.1136/bmj.j2837. No abstract available.

PMID:
28615287
12.

Chronic Cough.

Smith JA, Woodcock A.

N Engl J Med. 2017 Jan 12;376(2):183-184. doi: 10.1056/NEJMc1615067. No abstract available.

PMID:
28076718
13.

Mentor qualities that matter: The importance of perceived (not demographic) similarity.

Hernandez PR, Estrada M, Woodcock A, Schultz PW.

J Exp Educ. 2017;85(3):450-468. doi: 10.1080/00220973.2016.1246405. Epub 2016 Nov 8.

14.

Towards understanding and managing chronic cough.

Satia I, Badri H, Al-Sheklly B, Smith JA, Woodcock AA.

Clin Med (Lond). 2016 Dec;16(Suppl 6):s92-s97. Review.

15.

Chronic Cough.

Smith JA, Woodcock A.

N Engl J Med. 2016 Oct 20;375(16):1544-1551. Review. No abstract available.

PMID:
27797316
16.

Engineering Student's Ethical Awareness and Behavior: A New Motivational Model.

Bairaktarova D, Woodcock A.

Sci Eng Ethics. 2017 Aug;23(4):1129-1157. doi: 10.1007/s11948-016-9814-x. Epub 2016 Oct 17.

17.

Diversifying Science: Intervention Programs Moderate the Effect of Stereotype Threat on Motivation and Career Choice.

Woodcock A, Hernandez PR, Schultz PW.

Soc Psychol Personal Sci. 2016 Mar;7(2):184-192. Epub 2015 Sep 28.

18.

Effectiveness of Fluticasone Furoate-Vilanterol for COPD in Clinical Practice.

Vestbo J, Leather D, Diar Bakerly N, New J, Gibson JM, McCorkindale S, Collier S, Crawford J, Frith L, Harvey C, Svedsater H, Woodcock A; Salford Lung Study Investigators.

N Engl J Med. 2016 Sep 29;375(13):1253-60. doi: 10.1056/NEJMoa1608033. Epub 2016 Sep 4.

19.

Distress tolerance is linked to unhealthy eating through pain catastrophizing.

Emami AS, Woodcock A, Swanson HE, Kapphahn T, Pulvers K.

Appetite. 2016 Dec 1;107:454-459. doi: 10.1016/j.appet.2016.08.119. Epub 2016 Aug 30.

PMID:
27586411
20.

Well, I Wouldn't be Any Worse Off, Would I, Than I am Now? A Qualitative Study of Decision-Making, Hopes, and Realities of Adults With Type 1 Diabetes Undergoing Islet Cell Transplantation.

Speight J, Woodcock AJ, Reaney MD, Amiel SA, Johnson P, Parrott N, Rutter MK, Senior P, Shaw JA.

Transplant Direct. 2016 Apr 21;2(5):e72. doi: 10.1097/TXD.0000000000000581. eCollection 2016 May.

21.

What factors support older people to increase their physical activity levels? An exploratory analysis of the experiences of PACE-Lift trial participants.

Victor CR, Rogers A, Woodcock A, Beighton C, Cook DG, Kerry SM, Iliffe S, Whincup P, Ussher M, Harris TJ.

Arch Gerontol Geriatr. 2016 Nov-Dec;67:1-6. doi: 10.1016/j.archger.2016.06.006. Epub 2016 Jun 11.

22.

Community perceptions about the use of black salve.

Clark JJ, Woodcock A, Cipriano SD, Hyde MA, Edwards SL, Frost CJ, Eliason MJ.

J Am Acad Dermatol. 2016 May;74(5):1021-3. doi: 10.1016/j.jaad.2015.10.016. No abstract available.

PMID:
27085238
23.

Objective Cough Frequency, Airway Inflammation, and Disease Control in Asthma.

Marsden PA, Satia I, Ibrahim B, Woodcock A, Yates L, Donnelly I, Jolly L, Thomson NC, Fowler SJ, Smith JA.

Chest. 2016 Jun;149(6):1460-6. doi: 10.1016/j.chest.2016.02.676. Epub 2016 Mar 10.

PMID:
26973014
24.

Neurophenotypes in Airway Diseases. Insights from Translational Cough Studies.

Belvisi MG, Birrell MA, Khalid S, Wortley MA, Dockry R, Coote J, Holt K, Dubuis E, Kelsall A, Maher SA, Bonvini S, Woodcock A, Smith JA.

Am J Respir Crit Care Med. 2016 Jun 15;193(12):1364-72. doi: 10.1164/rccm.201508-1602OC.

25.

"It's not just about walking.....it's the practice nurse that makes it work": a qualitative exploration of the views of practice nurses delivering complex physical activity interventions in primary care.

Beighton C, Victor C, Normansell R, Cook D, Kerry S, Iliffe S, Ussher M, Whincup P, Fox-Rushby J, Woodcock A, Harris T.

BMC Public Health. 2015 Dec 12;15:1236. doi: 10.1186/s12889-015-2568-6.

26.

The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in asthma.

Woodcock A, Bakerly ND, New JP, Gibson JM, Wu W, Vestbo J, Leather D.

BMC Pulm Med. 2015 Dec 10;15:160. doi: 10.1186/s12890-015-0150-8.

27.

Detection of pepsin in sputum: a rapid and objective measure of airways reflux.

Strugala V, Woodcock AD, Dettmar PW, Faruqi S, Morice AH.

Eur Respir J. 2016 Jan;47(1):339-41. doi: 10.1183/13993003.00827-2015. Epub 2015 Nov 5. No abstract available.

28.

The Salford Lung Study protocol: a pragmatic, randomised phase III real-world effectiveness trial in chronic obstructive pulmonary disease.

Bakerly ND, Woodcock A, New JP, Gibson JM, Wu W, Leather D, Vestbo J.

Respir Res. 2015 Sep 4;16:101. doi: 10.1186/s12931-015-0267-6.

29.

Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma.

Bernstein DI, Bateman ED, Woodcock A, Toler WT, Forth R, Jacques L, Nunn C, O'Byrne PM.

J Asthma. 2015;52(10):1073-83. doi: 10.3109/02770903.2015.1056350. Epub 2015 Aug 18.

PMID:
26291137
30.

Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK).

Heaney LG, Djukanovic R, Woodcock A, Walker S, Matthews JG, Pavord ID, Bradding P, Niven R, Brightling CE, Chaudhuri R, Arron JR, Choy DF, Cowan D, Mansur A, Menzies-Gow A, Adcock I, Chung KF, Corrigan C, Coyle P, Harrison T, Johnston S, Howarth P, Lordan J, Sabroe I, Bigler J, Smith D, Catley M, May R, Pierre L, Stevenson C, Crater G, Keane F, Costello RW, Hudson V, Supple D, Hardman T.

Thorax. 2016 Feb;71(2):187-9. doi: 10.1136/thoraxjnl-2015-207326. Epub 2015 Jul 23. Review.

31.

Morphologic Characterization of Nerves in Whole-Mount Airway Biopsies.

West PW, Canning BJ, Merlo-Pich E, Woodcock AA, Smith JA.

Am J Respir Crit Care Med. 2015 Jul 1;192(1):30-9. doi: 10.1164/rccm.201412-2293OC.

32.

Using an electronic medical record (EMR) to conduct clinical trials: Salford Lung Study feasibility.

Elkhenini HF, Davis KJ, Stein ND, New JP, Delderfield MR, Gibson M, Vestbo J, Woodcock A, Bakerly ND.

BMC Med Inform Decis Mak. 2015 Feb 7;15:8. doi: 10.1186/s12911-015-0132-z.

33.

The Study Team for Early Life Asthma Research (STELAR) consortium 'Asthma e-lab': team science bringing data, methods and investigators together.

Custovic A, Ainsworth J, Arshad H, Bishop C, Buchan I, Cullinan P, Devereux G, Henderson J, Holloway J, Roberts G, Turner S, Woodcock A, Simpson A.

Thorax. 2015 Aug;70(8):799-801. doi: 10.1136/thoraxjnl-2015-206781. Epub 2015 Mar 24. Review.

34.

A primary care nurse-delivered walking intervention in older adults: PACE (pedometer accelerometer consultation evaluation)-Lift cluster randomised controlled trial.

Harris T, Kerry SM, Victor CR, Ekelund U, Woodcock A, Iliffe S, Whincup PH, Beighton C, Ussher M, Limb ES, David L, Brewin D, Adams F, Rogers A, Cook DG.

PLoS Med. 2015 Feb 17;12(2):e1001783. doi: 10.1371/journal.pmed.1001783. eCollection 2015 Feb.

35.

Complex interventions reduce use of urgent healthcare in adults with asthma: systematic review with meta-regression.

Blakemore A, Dickens C, Anderson R, Tomenson B, Woodcock A, Guthrie E.

Respir Med. 2015 Feb;109(2):147-56. doi: 10.1016/j.rmed.2014.11.002. Epub 2014 Nov 15. Review.

36.

Fluticasone furoate-vilanterol 100-25 mcg compared with fluticasone furoate 100 mcg in asthma: a randomized trial.

Bleecker ER, Lötvall J, O'Byrne PM, Woodcock A, Busse WW, Kerwin EM, Forth R, Medley HV, Nunn C, Jacques L, Bateman ED.

J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):553-61. doi: 10.1016/j.jaip.2014.02.010. Epub 2014 Apr 24.

PMID:
25213048
37.

Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial.

O'Byrne PM, Woodcock A, Bleecker ER, Bateman ED, Lötvall J, Forth R, Medley H, Jacques L, Busse WW.

Respir Res. 2014 Aug 11;15:88. doi: 10.1186/s12931-014-0088-z.

38.

Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial.

Busse WW, Bateman ED, O'Byrne PM, Lötvall J, Woodcock A, Medley H, Forth R, Jacques L.

Allergy. 2014 Nov;69(11):1522-30. doi: 10.1111/all.12480. Epub 2014 Aug 22.

39.

Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study.

Woodcock A, Lötvall J, Busse WW, Bateman ED, Stone S, Ellsworth A, Jacques L.

BMC Pulm Med. 2014 Jul 9;14:113. doi: 10.1186/1471-2466-14-113.

40.

Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids.

Lötvall J, Bateman ED, Busse WW, O'Byrne PM, Woodcock A, Toler WT, Jacques L, Goldfrad C, Bleecker ER.

J Negat Results Biomed. 2014 Jun 13;13(1):9. doi: 10.1186/1477-5751-13-9.

41.

Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease.

Hayat JO, Gabieta-Somnez S, Yazaki E, Kang JY, Woodcock A, Dettmar P, Mabary J, Knowles CH, Sifrim D.

Gut. 2015 Mar;64(3):373-80. doi: 10.1136/gutjnl-2014-307049. Epub 2014 May 7.

PMID:
24812000
42.

Which older people decline participation in a primary care trial of physical activity and why: insights from a mixed methods approach.

Rogers A, Harris T, Victor C, Woodcock A, Limb E, Kerry S, Iliffe S, Whincup P, Ekelund U, Beighton C, Ussher M, Adams F, Cook DG.

BMC Geriatr. 2014 Apr 12;14:46. doi: 10.1186/1471-2318-14-46.

43.

Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial.

Khalid S, Murdoch R, Newlands A, Smart K, Kelsall A, Holt K, Dockry R, Woodcock A, Smith JA.

J Allergy Clin Immunol. 2014 Jul;134(1):56-62. doi: 10.1016/j.jaci.2014.01.038. Epub 2014 Mar 22.

PMID:
24666696
44.

Obtaining real-world evidence: the Salford Lung Study.

New JP, Bakerly ND, Leather D, Woodcock A.

Thorax. 2014 Dec;69(12):1152-4. doi: 10.1136/thoraxjnl-2014-205259. Epub 2014 Mar 6. Erratum in: Thorax. 2015 Oct;70(10):1008.

45.
46.

Small Ubiquitin-like Modifier protein SUMO enables plants to control growth independently of the phytohormone gibberellin.

Conti L, Nelis S, Zhang C, Woodcock A, Swarup R, Galbiati M, Tonelli C, Napier R, Hedden P, Bennett M, Sadanandom A.

Dev Cell. 2014 Jan 13;28(1):102-10. doi: 10.1016/j.devcel.2013.12.004.

47.

Children must be protected from the tobacco industry's marketing tactics.

Hopkinson N, Wallis C, Higgins B, Gaduzo S, Sherrington R, Keilty S, Stern M, Britton J, Bush A, Moxham J, Sylvester K, Griffiths V, Sutherland T, Crossingham I, Raju R, Spencer C, Safavi S, Deegan P, Seymour J, Hickman K, Hughes J, Wieboldt J, Shaheen F, Peedell C, Mackenzie N, Nicholl D, Jolley C, Crooks G, Crooks G, Dow C, Deveson P, Bintcliffe O, Gray B, Kumar S, Haney S, Docherty M, Thomas A, Chua F, Dwarakanath A, Summers G, Prowse K, Lytton S, Ong YE, Graves J, Banerjee T, English P, Leonard A, Brunet M, Chaudhry N, Ketchell RI, Cummings N, Lebus J, Sharp C, Meadows C, Harle A, Stewart T, Parry D, Templeton-Wright S, Moore-Gillon J, Stratford- Martin J, Saini S, Matusiewicz S, Merritt S, Dowson L, Satkunam K, Hodgson L, Suh ES, Durrington H, Browne E, Walters N, Steier J, Barry S, Griffiths M, Hart N, Nikolic M, Berry M, Thomas A, Miller J, McNicholl D, Marsden P, Warwick G, Barr L, Adeboyeku D, Mohd Noh MS, Griffiths P, Davies L, Quint J, Lyall R, Shribman J, Collins A, Goldman J, Bloch S, Gill A, Man W, Christopher A, Yasso R, Rajhan A, Shrikrishna D, Moore C, Absalom G, Booton R, Fowler RW, Mackinlay C, Sapey E, Lock S, Walker P, Jha A, Satia I, Bradley B, Mustfa N, Haqqee R, Thomas M, Patel A, Redington A, Pillai A, Keaney N, Fowler S, Lowe L, Brennan A, Morrison D, Murray C, Hankinson J, Dutta P, Maddocks M, Pengo M, Curtis K, Rafferty G, Hutchinson J, Whitfield R, Turner S, Breen R, Naveed SU, Goode C, Esterbrook G, Ahmed L, Walker W, Ford D, Connett G, Davidson P, Elston W, Stanton A, Morgan D, Myerson J, Maxwell D, Harrris A, Parmar S, Houghton C, Winter R, Puthucheary Z, Thomson F, Sturney S, Harvey J, Haslam PL, Patel I, Jennings D, Range S, Mallia-Milanes B, Collett A, Tate P, Russell R, Feary J, O'Driscoll R, Eaden J, Round J, Sharkey E, Montgomery M, Vaughan S, Scheele K, Lithgow A, Partridge S, Chavasse R, Restrick L, Agrawal S, Abdallah S, Lacy-Colson A, Adams N, Mitchell S, Haja Mydin H, Ward A, Denniston S, Steel M, Ghosh D, Connellan S, Rigge L, Williams R, Grove A, Anwar S, Dobson L, Hosker H, Stableforth D, Greening N, Howell T, Casswell G, Davies S, Tunnicliffe G, Mitchelmore P, Phitidis E, Robinson L, Prowse K, Bafadhel M, Robinson G, Boland A, Lipman M, Bourke S, Kaul S, Cowie C, Forrest I, Starren E, Burke H, Furness J, Bhowmik A, Everett C, Seaton D, Holmes S, Doe S, Parker S, Graham A, Paterson I, Maqsood U, Ohri C, Iles P, Kemp S, Iftikhar A, Carlin C, Fletcher T, Emerson P, Beasley V, Ramsay M, Buttery R, Mungall S, Crooks S, Ridyard J, Ross D, Guadagno A, Holden E, Coutts I, Cullen K, O'Connor S, Barker J, Sloper K, Watson J, Smith P, Anderson P, Brown L, Nyman C, Milburn H, Clive A, Serlin M, Bolton C, Fuld J, Powell H, Dayer M, Woolhouse I, Georgiadi A, Leonard H, Dodd J, Campbell I, Ruiz G, Zurek A, Paton JY, Malin A, Wood F, Hynes G, Connell D, Spencer D, Brown S, Smith D, Cooper D, O'Kane C, Hicks A, Creagh-Brown B, Lordan J, Nickol A, Primhak R, Fleming L, Powrie D, Brown J, Zoumot Z, Elkin S, Szram J, Scaffardi A, Marshall R, Macdonald I, Lightbody D, Farmer R, Wheatley I, Radnan P, Lane I, Booth A, Tilbrook S, Capstick T, Hewitt L, McHugh M, Nelson C, Wilson P, Padmanaban V, White J, Davison J, O'Callaghan U, Hodson M, Edwards J, Campbell C, Ward S, Wooler E, Ringrose E, Bridges D, Matthew Hodson, John Edwards, Colin Campbell, Simon Ward, Edwina Wooler, Elizabeth Ringrose, Diana Bridges, Rosalind Backham, Kim Randall, Tracey Mathieson, Long A, Parkes M, Clarke S, Allen B, Connelly C, Forster G, Hoadley J, Martin K, Barnham K, Khan K, Munday M, Edwards C, O'Hara D, Turner S, Pieri-Davies S, Ford K, Daniels T, Wright J, Towns R, Fern K, Butcher J, Burgin K, Winter B, Freeman D, Olive S, Gray L, Pye K, Roots D, Cox N, Davies CA, Wicker J, Hilton K, Lloyd J, MacBean V, Wood M, Kowal J, Downs J, Ryan H, Guyatt F, Nicoll D, Lyons E, Narasimhan D, Rodman A, Walmsley S, Newey A, Buxton M, Dewar M, Cooper A, Reilly J, Lloyd J, Macmillan AB, Roots D, Olley A, Voase N, Martin S, McCarvill I, Christensen A, Agate R, Heslop K, Timlett A, Hailes K, Davey C, Pawulska B, Lane A, Ioakim S, Hough A, Treharne J, Jones H, Winter-Burke A, Miller L, Connolly B, Bingham L, Fraser U, Bott J, Johnston C, Graham A, Curry D, Sumner H, Costello CA, Bartoszewicz C, Badman R, Williamson K, Taylor A, Purcell H, Barnett E, Molloy A, Crawfurd L, Collins N, Monaghan V, Mir M, Lord V, Stocks J, Edwards A, Greenhalgh T, Lenney W, McKee M, McAuley D, Majeed A, Cookson J, Baker E, Janes S, Wedzicha W, Lomas Dean D, Harrison B, Davison T, Calverley P, Wilson R, Stockley R, Ayres J, Gibson J, Simpson J, Burge S, Warner J, Lenney W, Thomson N, Davies P, Woodcock A, Woodhead M, Spiro S, Ormerod L, Bothamley G, Partridge M, Shields M, Montgomery H, Simonds A, Barnes P, Durham S, Malone S, Arabnia G, Olivier S, Gardiner K, Edwards S.

BMJ. 2013 Dec 9;347:f7358. doi: 10.1136/bmj.f7358. No abstract available.

48.

Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: a 24-week placebo and active-controlled randomised trial.

Lötvall J, Bleecker ER, Busse WW, O'Byrne PM, Woodcock A, Kerwin EM, Stone S, Forth R, Jacques L, Bateman ED.

Respir Med. 2014 Jan;108(1):41-9. doi: 10.1016/j.rmed.2013.11.009. Epub 2013 Nov 19. Erratum in: Respir Med. 2015 Jan;109(1):146.

49.

Sustaining Optimal Motivation: A Longitudinal Analysis of Interventions to Broaden Participation of Underrepresented Students in STEM.

Hernandez PR, Schultz PW, Estrada M, Woodcock A, Chance RC.

J Educ Psychol. 2013 Feb 1;105(1). doi: 10.1037/a0029691.

50.

Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone.

Bateman ED, O'Byrne PM, Busse WW, Lötvall J, Bleecker ER, Andersen L, Jacques L, Frith L, Lim J, Woodcock A.

Thorax. 2014 Apr;69(4):312-9. doi: 10.1136/thoraxjnl-2013-203600. Epub 2013 Nov 19.

Supplemental Content

Loading ...
Support Center